
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            CAR-T cell therapy in china: innovations, challenges, and strategic pathways - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532C3B8AF1ECE3052C3B00466E66D4.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="discon">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373616/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Discover Oncology">
<meta name="citation_title" content="CAR-T cell therapy in china: innovations, challenges, and strategic pathways">
<meta name="citation_author" content="Lihui Yan">
<meta name="citation_author_institution" content="Department of Pain Relief Therapeutic, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital &amp; Institute, Shenyang, China">
<meta name="citation_author" content="Boshi Duan">
<meta name="citation_author_institution" content="Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital &amp; Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China">
<meta name="citation_author" content="Peng Sun">
<meta name="citation_author_institution" content="Department of Hand Surgery 4 Ward, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China">
<meta name="citation_author" content="Tianzuo Wang">
<meta name="citation_author_institution" content="Shenyang No. 126 Middle School, Shenyang, China">
<meta name="citation_author" content="Tianyou Wang">
<meta name="citation_author_institution" content="Shenyang No. 126 Middle School, Shenyang, China">
<meta name="citation_author" content="Shuang Jiang">
<meta name="citation_author_institution" content="Psychology Clinic, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital &amp; Institute, Shenyang, China">
<meta name="citation_author" content="Yue Wang">
<meta name="citation_author_institution" content="Department of General Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital &amp; Institute, Shenyang, China">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="16">
<meta name="citation_firstpage" content="1593">
<meta name="citation_doi" content="10.1007/s12672-025-03282-9">
<meta name="citation_pmid" content="40844635">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373616/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373616/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373616/pdf/12672_2025_Article_3282.pdf">
<meta name="description" content="Cancer immunotherapy has transformed oncology, with CAR-T cell therapy emerging as a cornerstone of personalized treatment for hematologic malignancies. In China, rapid advancements in domestically developed CAR-T therapies have achieved clinical ...">
<meta name="og:title" content="CAR-T cell therapy in china: innovations, challenges, and strategic pathways">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Cancer immunotherapy has transformed oncology, with CAR-T cell therapy emerging as a cornerstone of personalized treatment for hematologic malignancies. In China, rapid advancements in domestically developed CAR-T therapies have achieved clinical ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373616/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12373616">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s12672-025-03282-9"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12672_2025_Article_3282.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373616%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12373616/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12373616/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373616/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-discon.png" alt="Discover Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Discover Oncology" title="Link to Discover Oncology" shape="default" href="https://doi.org/10.1007/s12672-025-03282-9" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Discov Oncol</button></div>. 2025 Aug 22;16:1593. doi: <a href="https://doi.org/10.1007/s12672-025-03282-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s12672-025-03282-9</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Discov%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Discov%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Discov%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Discov%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>CAR-T cell therapy in china: innovations, challenges, and strategic pathways</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yan%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Lihui Yan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Lihui Yan</span></h3>
<div class="p">
<sup>1</sup>Department of Pain Relief Therapeutic, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital &amp; Institute, Shenyang, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yan%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lihui Yan</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duan%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Boshi Duan</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Boshi Duan</span></h3>
<div class="p">
<sup>2</sup>Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital &amp; Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duan%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Boshi Duan</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Peng Sun</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Peng Sun</span></h3>
<div class="p">
<sup>3</sup>Department of Hand Surgery 4 Ward, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peng Sun</span></a>
</div>
</div>
<sup>3,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Tianzuo Wang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Tianzuo Wang</span></h3>
<div class="p">
<sup>4</sup>Shenyang No. 126 Middle School, Shenyang, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tianzuo Wang</span></a>
</div>
</div>
<sup>4,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Tianyou Wang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Tianyou Wang</span></h3>
<div class="p">
<sup>4</sup>Shenyang No. 126 Middle School, Shenyang, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tianyou Wang</span></a>
</div>
</div>
<sup>4,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Shuang Jiang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Shuang Jiang</span></h3>
<div class="p">
<sup>5</sup>Psychology Clinic, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital &amp; Institute, Shenyang, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuang Jiang</span></a>
</div>
</div>
<sup>5,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Yue Wang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Yue Wang</span></h3>
<div class="p">
<sup>6</sup>Department of General Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital &amp; Institute, Shenyang, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yue Wang</span></a>
</div>
</div>
<sup>6,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Pain Relief Therapeutic, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital &amp; Institute, Shenyang, China </div>
<div id="Aff2">
<sup>2</sup>Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital &amp; Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China </div>
<div id="Aff3">
<sup>3</sup>Department of Hand Surgery 4 Ward, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China </div>
<div id="Aff4">
<sup>4</sup>Shenyang No. 126 Middle School, Shenyang, China </div>
<div id="Aff5">
<sup>5</sup>Psychology Clinic, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital &amp; Institute, Shenyang, China </div>
<div id="Aff6">
<sup>6</sup>Department of General Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital &amp; Institute, Shenyang, China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 4; Accepted 2025 Jul 23; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12373616  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40844635/" class="usa-link">40844635</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Cancer immunotherapy has transformed oncology, with CAR-T cell therapy emerging as a cornerstone of personalized treatment for hematologic malignancies. In China, rapid advancements in domestically developed CAR-T therapies have achieved clinical outcomes comparable to global benchmarks, with overall response rates (ORR) of 79–89% in B-cell malignancies and 64% 12-month progression-free survival in multiple myeloma. Despite these successes, CAR-T application in solid tumors remains hindered by antigen heterogeneity, immunosuppressive microenvironments, and on-target/off-tumor toxicity. To address these barriers, China has pioneered innovative strategies, including dual-target CAR-T constructs, armored CAR-Ts secreting immunomodulatory cytokines, and synergistic integration with traditional Chinese medicine, which enhances CAR-T efficacy by inhibiting myeloid-derived suppressor cells and reducing cytokine release syndrome. Notably, preclinical studies demonstrate that Huangqin increases tumor regression rates from 40 to 65% in lung cancer models when combined with CAR-T therapy. Concurrently, China is reshaping accessibility through policy innovations such as the “1 + 3 + N” multi-tiered payment system and regional insurance pilots, which reduce patient costs by 50%. Strategic investments in automated manufacturing and global regulatory harmonization further position China as a leader in cost-effective CAR-T development. However, challenges persist in solid tumor targeting, international market integration, and long-term safety monitoring. Future directions emphasize precision engineering, AI-driven treatment optimization, and cross-border collaborations to advance next-generation therapies. By balancing innovation, affordability, and policy agility, China is poised to drive the global evolution of cancer immunotherapy while addressing unmet needs in both hematologic and solid malignancies.</p>
<section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Tumor immunotherapy, Immune cell therapy, Immune checkpoint therapy, CAR-T, Bispecific antibodies</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Cancer immunotherapy has revolutionized oncology by reprogramming the immune system to target malignancies, with chimeric antigen receptor T-cell (CAR-T) therapy emerging as a transformative approach for hematologic cancers. While immune checkpoint inhibitors (ICIs) and bispecific antibodies (BsAbs) have expanded therapeutic options, CAR-T therapy stands at the forefront of personalized immunotherapy due to its ability to engineer patient-derived T cells for precise tumor targeting and eradication [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Since the 2017 FDA approval of CD19-targeted CAR-T therapies, this approach has achieved unprecedented success in relapsed/refractory B-cell malignancies, with complete remission rates exceeding 50% in global trials [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. In China, the development of CAR-T therapy has accelerated rapidly, with four domestically developed products, such as Arelcabtagene autoleucel and Equecabtagene autoleucel, approved for lymphoma and myeloma since 2021. These therapies have demonstrated comparable efficacy to their Western counterparts while addressing unique regional challenges, including cost and manufacturing scalability [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Despite these advances, CAR-T therapy faces limitations in treating solid tumors due to antigen heterogeneity and immunosuppressive tumor microenvironments—challenges that are also shared, to varying degrees, by ICIs and BsAbs [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. ICIs, exemplified by PD-1/PD-L1 inhibitors, have shown durable responses in select solid tumors but are hindered by primary resistance [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Similarly, BsAbs, such as Emicizumab and Epcoritamab, bridge immune and tumor cells but are limited by cytokine release syndrome (CRS) and antigen diversity [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. In contrast, CAR-T research in China has prioritized overcoming these barriers through innovative strategies such as dual-target CAR-Ts (e.g., CD19/BCMA), armored CAR-Ts that secrete immunostimulatory cytokines, and integration with traditional Chinese medicine to modulate the tumor microenvironment [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>–<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. This review focuses on CAR-T therapy as the central pillar of China’s advancements in immunotherapy, contextualizing its progress relative to global benchmarks. It also briefly discusses the complementary roles of ICIs and BsAbs. By analyzing clinical outcomes, regulatory frameworks, and cost-optimization strategies unique to China, we aim to highlight the growing influence of Chinese research in shaping the future of cancer immunotherapy.</p></section><section id="Sec2"><h2 class="pmc_sec_title">CAR-T therapy: hematologic vs. solid tumors</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Success in hematologic malignancies</h3>
<p id="Par3">CAR-T cell therapy has emerged as a groundbreaking advancement in the treatment of hematologic cancers, leveraging the ability of engineered T cells to specifically target tumor antigens such as CD19 and BCMA[<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The clinical success of CAR-T therapies, including Arelcabtagene autoleucel and Equecabtagene autoleucel in China, underscores the transformative potential of personalized immunotherapy in cancer treatment. These therapies have demonstrated remarkable clinical outcomes, with ORR of 79–89% for CD19-targeted CAR-T in B-ALL from Chinese Phase II single-arm trials (e.g., Arelcabtagene autoleucel, NCT03563810) [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>] and 89.6% ORR for BCMA CAR-T (Equecabtagene autoleucel) in multiple myeloma from the FUMANBA-1 trial (NCT03784192), a single-arm nonrandomized study [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. The 64% 12-month PFS in multiple myeloma surpasses historical chemotherapy outcomes and is derived from the same Chinese trial [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Recently, there has been growing interest in the potential synergy between CAR-T therapy and traditional Chinese medicine (TCM), particularly Huangqin (Scutellaria baicalensis), in modulating the tumor microenvironment and enhancing treatment efficacy. As noted, active components of Huangqin, such as baicalin and baicalein, have shown significant promise in reducing the immunosuppressive effects within the tumor microenvironment. This is primarily attributed to their ability to inhibit myeloid-derived suppressor cells (MDSCs) and reduce the levels of suppressive cytokines, such as IL-10 and TGF-β, which typically attenuate immune responses [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>–<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Additionally, Huangqin promotes the upregulation of pro-inflammatory cytokines such as interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α), which enhance T cell activation and prevent T cell exhaustion, a critical challenge in optimizing CAR-T therapy efficacy [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>].</p>
<p id="Par4">Preclinical studies suggest a potential synergistic effect between Huangqin (Scutellaria baicalensis) components (e.g., baicalin/baicalein) and CAR-T therapy in human non-small cell lung cancer xenograft models established with NCI-H1975 cells in immunocompromised NSG mice. Baicalein modulates the immune microenvironment by inhibiting MDSCs, with single-agent baicalin/baicalein showing 30%−60% tumor inhibition rates [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>–<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>] and CAR-T monotherapy achieving 20%−60% response rates in preclinical settings [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Specifically, in a murine xenograft model of lung cancer (<em>n</em> = 12 per group) treated with the combination of Huangqin extract (200 mg/kg, intragastric administration, daily for 21 days) and CD133-targeted CAR-T cells (1 × 10^6 cells/mouse, intravenous injection on day 7), the tumor regression rate was significantly increased from 40% (CAR-T monotherapy group) to 65% (combination group) (<em>p</em> &lt; 0.01, χ² test). This significant improvement in tumor regression indicates a robust synergistic effect between Huangqin and CAR-T therapy in this preclinical model. These results, together with preliminary clinical data showing improved overall response rates and reduced severity of cytokine release syndrome (CRS) when Huangqin is combined with CAR-T, suggest that TCM may offer an innovative approach to improving CAR-T therapy outcomes, particularly in solid tumors [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. The integration of such therapies could not only improve the efficacy of CAR-T in solid tumors but also enhance its potential in hematologic malignancies, offering a multifaceted approach to treat diverse patient populations [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. The combination of CAR-T therapy with TCM represents an exciting frontier in cancer immunotherapy, exemplifying the broader trend of integrating modern medical technologies with traditional approaches to address the complex challenges of cancer treatment. Emerging evidence suggests that this integrated strategy could lead to more durable and comprehensive responses, both in hematologic and solid tumors. Besides, Quantitative Comparison Table of Chinese vs. US CAR-T Efficacy is in Table <a href="#Tab1" class="usa-link">1</a>.<a href="#Fn1" class="usa-link">1</a></p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Quantitative comparison table of Chinese vs. US CAR-T efficacy</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Malignancy</th>
<th align="left" colspan="1" rowspan="1">Chinese CAR-T therapy</th>
<th align="left" colspan="1" rowspan="1">Efficacy data</th>
<th align="left" colspan="1" rowspan="1">US CAR-T therapy</th>
<th align="left" colspan="1" rowspan="1">Efficacy data</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>DLBCL</strong>
</td>
<td align="left" colspan="1" rowspan="1">Arelcabtagene autoleucel</td>
<td align="left" colspan="1" rowspan="1">ORR 79–89%</td>
<td align="left" colspan="1" rowspan="1">Yescarta</td>
<td align="left" colspan="1" rowspan="1">ORR 72%</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Multiple myeloma</strong>
</td>
<td align="left" colspan="1" rowspan="1">Equecabtagene autoleucel</td>
<td align="left" colspan="1" rowspan="1">ORR 89.6%, 12-mo PFS 64%</td>
<td align="left" colspan="1" rowspan="1">Abecma</td>
<td align="left" colspan="1" rowspan="1">ORR 72%, 12-mo PFS 58%</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>B-ALL</strong>
</td>
<td align="left" colspan="1" rowspan="1">CD19-targeted CAR-T</td>
<td align="left" colspan="1" rowspan="1">ORR 79–89%</td>
<td align="left" colspan="1" rowspan="1">Tisagenlecleucel</td>
<td align="left" colspan="1" rowspan="1">ORR 81%</td>
<td align="left" colspan="1" rowspan="1"> [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec4"><h3 class="pmc_sec_title">Challenges in solid tumors</h3>
<p id="Par7">The application of CAR-T therapy to solid tumors is hindered by three interconnected challenges related to tumor biology and the complexity of the tumor microenvironment (TME). First, antigen heterogeneity presents a significant obstacle, as solid tumors do not exhibit the uniform expression of lineage-specific antigens seen in hematologic malignancies. For example, glypican-3 (GPC3), a frequently targeted antigen in Chinese clinical trials for hepatocellular carcinoma (HCC), is expressed in only 40–60% of HCC patients in China, resulting in incomplete tumor cell eradication and eventual relapse [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Similarly, Claudin18.2, a promising gastric cancer target in China, demonstrates variable expression across different tumor subtypes, complicating patient selection [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Second, the immunosuppressive TME in solid tumors severely impairs CAR-T cell efficacy. Elevated levels of TGF-β and IL-10 in solid tumors from Chinese patients have been shown to suppress CAR-T cell proliferation and cytotoxicity by upregulating exhaustion markers such as TIM-3 and LAG-3 [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. A study further revealed that gastric cancer stromal cells reduced CAR-T cytotoxicity by 70% through dual PD-L1 and indoleamine 2,3-dioxygenase (IDO)-mediated immunosuppression, underscoring the critical role of the TME in resistance to therapy [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Third, on-target/off-tumor toxicity remains a major safety concern. Targeting antigens like Claudin18.2, which is expressed in 60% of Chinese gastric cancers as well as in normal gastric mucosa, has led to severe adverse effects [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. In a Phase I, single-center, open-label trial (<em>N</em> = 36) of Claudin18.2-targeted CAR-T therapy (CT041) in advanced gastric cancer, 28% (10/36) of patients developed grade ≥ 3 gastritis due to off-tumor toxicity toward healthy gastric mucosa [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. This highlights the delicate balance between efficacy and safety in solid tumor CAR-T applications, where antigen expression on normal tissues remains a critical challenge. These challenges collectively underscore the need for innovative strategies to enhance antigen specificity, modulate the TME, and mitigate off-tumor effects in CAR-T therapies for solid tumors.</p></section></section><section id="Sec5"><h2 class="pmc_sec_title">China’s strategic innovations and future directions</h2>
<section id="Sec6"><h3 class="pmc_sec_title">Novel targets and cost optimization</h3>
<p id="Par8">China is at the forefront of developing innovative solutions to address the challenges associated with CAR-T therapy in solid tumors. These strategies include novel target development, combination therapies, and cost-reduction initiatives [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Target innovation has become a key feature of CAR-T research in China. Approximately 43% of Chinese clinical trials for solid tumors focus on glypican-3 (GPC3) in hepatocellular carcinoma (HCC) and Claudin18.2 (CLDN18.2) in gastric cancer, compared to just 22% of global trials targeting HER2/PSMA. For instance, the <a href="https://clinicaltrials.gov/ct2/show/NCT04503980" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04503980</a> trial of CLDN18.2-targeted CAR-T (CT041) in advanced gastric cancer achieved an objective response rate (ORR) of 48.6%, which is notably higher than the 32% ORR reported in HER2-targeted CAR-T trials in the United States [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Remarkably, CT041 demonstrated a disease control rate (DCR) of 75.5% in gastrointestinal tumors, with complete tumor regression observed in some heavily pretreated patients, including those with pancreatic cancer [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Another emerging approach involves the combination of CAR-T with traditional Chinese medicine (TCM). The compound Huangqin (Scutellaria baicalensis) has been shown to enhance CAR-T persistence by inhibiting myeloid-derived suppressor cells (MDSCs) in preclinical lung cancer models [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. This strategy leverages TCM’s immunomodulatory properties to counteract the immunosuppressive tumor microenvironment (TME), which is a significant barrier in solid tumors. Additionally, cost-reduction strategies through streamlined manufacturing and policy innovation are reshaping the accessibility of CAR-T therapies [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Despite four unsuccessful attempts to list CAR-T in China’s National Reimbursement Drug List (NRDL) due to pricing disputes, a multi-tiered payment system (“1 + 3 + N”)—combining basic insurance, commercial insurance, and patient co-payment—is being explored to improve affordability [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. These efforts aim to strike a balance between sustainable innovation and patient access, positioning China as a leading global player in cost-effective CAR-T development. Figure 1 showed the technological innovation directions of China’s CAR-T therapy</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373616_12672_2025_3282_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e94/12373616/ae37adfac1ee/12672_2025_3282_Fig1_HTML.jpg" loading="lazy" id="MO1" height="285" width="709" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Technological innovation directions of China's CAR-T therapy</p></figcaption></figure></section><section id="Sec7"><h3 class="pmc_sec_title">Policy synergy and global collaboration</h3>
<p id="Par9">In recent years, the rapid development of CAR-T therapy in China has prompted the government to explore pilot programs and multi-tiered payment models to alleviate the financial burden on patients [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. One notable initiative is the “Hu Hui Bao” program, launched in 2023 in Shanghai. This program offers up to 50% reimbursement for eligible CAR-T treatments, significantly reducing out-of-pocket expenses for patients. For instance, a patient undergoing CAR-T therapy with Yescarta<sup>®</sup> (priced at 1.2 million RMB) could receive a 500,000 RMB payout from Hu Hui Bao, reducing their out-of-pocket drug cost by 41.7% (from 1.2 million to 700,000 RMB) [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. As of March 2024, the program has reimbursed over 33 million RMB for CAR-T treatments, benefiting nearly 60 patients in Shanghai [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Notably, this coverage applies solely to CAR-T drug costs and does not include hospitalization, nursing, or other treatment-related expenses. Actual out-of-pocket costs may still exceed 60% of total treatment fees, depending on additional medical needs [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Initial reports indicate that the program is available at key medical institutions in both urban and suburban areas of Shanghai. During its implementation, the program has adhered to principles of fairness, ensuring that all eligible patients have access. Moreover, it has emphasized the collection of real-time data and performance evaluations. Early feedback suggests that “Hu Hui Bao” has substantially reduced patient costs, enhanced treatment coverage, and increased patient satisfaction. Despite these promising results in Shanghai, the program has not yet been expanded nationwide. To further internationalize CAR-T therapy, China is actively seeking collaboration with global markets by attracting international investment, enhancing cross-border regulatory coordination, and adopting international standards [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. These efforts aim not only to reduce treatment costs but also to create favorable conditions for Chinese CAR-T products to enter the global market, thereby establishing a complementary and mutually beneficial development model both domestically and internationally [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>].</p></section><section id="Sec8"><h3 class="pmc_sec_title">Future technological pathways</h3>
<p id="Par10">Looking ahead, the field of cancer immunotherapy is poised for significant breakthroughs in precision medicine, cell engineering, and combination therapies. Advanced techniques such as single-cell sequencing and spatial transcriptomics are expected to refine patient stratification, as demonstrated by emerging trials identifying predictive biomarkers for CAR-T efficacy in solid tumors [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Additionally, “armored” CAR-T cells, engineered to secrete IL-12 or resist TGF-β signaling, are showing promising results in early-phase clinical trials, improving persistence and efficacy within immunosuppressive microenvironments [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. In the field of bispecific antibodies (BsAbs), research is expanding beyond dual immune checkpoint blockade to incorporate novel antigen pairs, addressing both tumor heterogeneity and immune suppression [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. Furthermore, the rapid evolution of artificial intelligence (AI) and machine learning is transforming telemedicine platforms, enabling real-time monitoring and dynamic adjustment of immunotherapy regimens based on predictive analytics [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Meanwhile, immune checkpoint inhibitors (ICIs) continue to advance, with next-generation targets such as LAG-3 and TIM-3 aimed at overcoming resistance and expanding their applicability to a broader range of solid tumors [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. Despite these advances, challenges such as tumor heterogeneity, resistance, and immune-related adverse events (irAEs) remain substantial obstacles [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. Future strategies will focus on multi-omics integration and personalized treatment protocols, leveraging predictive biomarkers to enhance efficacy while minimizing toxicity. These efforts are expected to propel cancer immunotherapy toward greater maturity and broader global adoption.</p></section></section><section id="Sec9"><h2 class="pmc_sec_title">Strategies for china’s CAR-T therapies</h2>
<p id="Par11">Table <a href="#Tab2" class="usa-link">2</a> compares the CAR-T development strategies, highlighting key differences between China and Western countries. In Western countries, CAR-T development predominantly focuses on specific cancer types and highly personalized treatment protocols, relying on well-established technological platforms [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. In contrast, China places a strong emphasis on cost-effectiveness in CAR-T research, while accelerating clinical trial progress, supported by robust policy backing and advantageous market access [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. Additionally, Western countries tend to impose more stringent drug regulations and data accumulation standards, whereas China benefits from more flexible approval processes and faster market promotion [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. Based on the comparative analysis in Table <a href="#Tab1" class="usa-link">1</a>, this paper suggests three key strategies for China to enhance the accessibility and international competitiveness of its CAR-T therapies by drawing from the experiences of Western countries. First, China could expand insurance pilot programs, inspired by the Shanghai “Hu Hui Bao” initiative, which provided 50% reimbursement for CAR-T treatments in 2023. Extending similar pilot programs to high-demand regions such as Beijing and Guangdong, along with adopting an outcome-based payment model, could link reimbursement rates to CAR-T efficacy, thus alleviating financial pressures on national insurance funds. Second, China could accelerate conditional approvals by implementing real-world data (RWE) requirements, following the FDA’s Regenerative Medicine Advanced Therapy (RMAT) and Breakthrough Therapy (BPR) pathways. This approach would broaden the scope of conditional approvals and ensure long-term safety and efficacy monitoring while expediting CAR-T market entry. Finally, China should promote automated CAR-T manufacturing for scaled production. Western CAR-T manufacturers, such as Novartis, have implemented fully automated cell processing systems (e.g., the Prodigy system) to reduce costs and shorten production cycles. China should invest in similar automation technologies and optimize local supply chains to further reduce CAR-T treatment costs and enhance affordability.</p>
<section class="tw xbox font-sm" id="Tab2"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>CAR-T development strategy comparison: China vs. Western countries</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Dimension</th>
<th align="left" colspan="1" rowspan="1">China</th>
<th align="left" colspan="1" rowspan="1">Western countries</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Key Targets</td>
<td align="left" colspan="1" rowspan="1">CD19, BCMA, GPC3, Claudin18.2</td>
<td align="left" colspan="1" rowspan="1">CD19, BCMA, HER2, PSMA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cost (Per Treatment)</td>
<td align="left" colspan="1" rowspan="1">$150,000</td>
<td align="left" colspan="1" rowspan="1">$400,000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Regulatory Pathway</td>
<td align="left" colspan="1" rowspan="1">Conditional approval + real-world evidence</td>
<td align="left" colspan="1" rowspan="1">FDA accelerated approval (RMAT/BPR)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Payment Model</td>
<td align="left" colspan="1" rowspan="1">1 + 3 + N multi-tier system</td>
<td align="left" colspan="1" rowspan="1">Outcome-based payment + commercial insurance</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Manufacturing Process</td>
<td align="left" colspan="1" rowspan="1">Localized supply chain, optimized automation</td>
<td align="left" colspan="1" rowspan="1">Bioreactors like Novartis Prodigy system</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Insurance Coverage</td>
<td align="left" colspan="1" rowspan="1">Regional pilots (e.g., Shanghai “Hu Hui Bao” covers 50%)</td>
<td align="left" colspan="1" rowspan="1">Primarily covered by private insurance, some government programs</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Indication Expansion</td>
<td align="left" colspan="1" rowspan="1">Focused on solid tumors (e.g., GPC3 for HCC, Claudin18.2 for gastric cancer)</td>
<td align="left" colspan="1" rowspan="1">Mainly hematologic malignancies, limited solid tumor trials (HER2, PSMA)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical Trials</td>
<td align="left" colspan="1" rowspan="1">Real-world evidence included in regulatory approval, shorter trial cycles</td>
<td align="left" colspan="1" rowspan="1">Large-scale RCTs, longer approval cycles</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec10"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par13">In conclusion, tumor immunotherapy has fundamentally transformed cancer treatment worldwide, with CAR-T cell therapy emerging as a cornerstone, particularly for hematologic malignancies. China’s rapid advancements in domestically developed CAR-T therapies have positioned it as a front-runner in the global landscape, marked by three key quantified milestones: clinical efficacy with overall response rates (ORRs) of 79–89% in B-cell malignancies and 64% 12-month progression-free survival (PFS) in multiple myeloma, comparable to international benchmarks; cost reduction through regional insurance pilots like “Hu Hui Bao,” which slashed patient out-of-pocket expenses by 41.7% and reimbursed over 33 million RMB for CAR-T treatments as of March 2024; and enhanced patient accessibility, with the multi-tiered payment system extending coverage to over 60 patients in Shanghai while ensuring equity across urban and suburban medical institutions. Despite these achievements, challenges remain in internationalizing CAR-T products, including gaining global regulatory recognition, harmonizing production standards, and addressing market competition. Future strategies should focus on optimizing policies, advancing automated manufacturing, fostering cross-border collaborations, and integrating innovations like traditional Chinese medicine—efforts essential for ensuring Chinese CAR-T therapies continue to benefit domestic patients and achieve broader global adoption.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>LY, BD, PS, TW, TW，SJ and YW wrote the main manuscript text. All authors reviewed the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by the National Natural Science Cultivation Foundation of China of Liaoning Cancer Hospital (2021-ZLLH-18); The Natural Science Foundation of Liaoning (2024-MS-266); Shenzhen High-level Hospital Construction Fund; The Shenzhen Science and Technology Program (SGDX20201103095614039).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">
<strong>Ethics</strong>,<strong> consent to participate</strong>,<strong> and consent to publish </strong>
</h3>
<p id="Par14">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par15">The authors declare no competing interests.</p></section><section id="FPar3"><h3 class="pmc_sec_title"><strong>Clinical trial number</strong></h3>
<p id="Par16">Not applicable.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="Fn1">
<sup>1</sup><p class="display-inline" id="Par5">DLBCL (Diffuse Large B-Cell Lymphoma);B-ALL (B-cell Acute Lymphoblastic Leukemia)</p>
</div>
<div class="fn p" id="fn2">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn3"><p>Lihui Yan, Boshi Duan, Peng Sun and Tianzuo Wang are the co-first authors.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Shuang Jiang, Email: 347526107@qq.com.</p>
<p>Yue Wang, Email: wangyue1@cancerhosp-ln-cmu.com.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Maalej KM, Merhi M, Inchakalody VP, et al. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer. 2023;22(1):20.
</cite> [<a href="https://doi.org/10.1186/s12943-023-01723-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9885707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36717905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maalej%20KM,%20Merhi%20M,%20Inchakalody%20VP,%20et%20al.%20CAR-cell%20therapy%20in%20the%20era%20of%20solid%20tumor%20treatment:%20current%20challenges%20and%20emerging%20therapeutic%20advances.%20Mol%20Cancer.%202023;22(1):20." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Reiss KA, Angelos MG, Dees EC et al. CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial. Nat Med. 22025;31:1171–1182.</cite> [<a href="https://doi.org/10.1038/s41591-025-03495-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39920391/" class="usa-link">PubMed</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Cappell KM, Kochenderfer JN, et al. Long-term outcomes following CAR T cell therapy: what we know so Far. Nat Rev Clin Oncol. 2023;20:359–71.
</cite> [<a href="https://doi.org/10.1038/s41571-023-00754-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10100620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37055515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cappell%20KM,%20Kochenderfer%20JN,%20et%20al.%20Long-term%20outcomes%20following%20CAR%20T%20cell%20therapy:%20what%20we%20know%20so%20Far.%20Nat%20Rev%20Clin%20Oncol.%202023;20:359%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Nishida T, Kataoka H, et al. Glypican 3-Targeted therapy in hepatocellular carcinoma. Cancers (Basel). 2019;11(9):1339.
</cite> [<a href="https://doi.org/10.3390/cancers11091339" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6770328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31510063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nishida%20T,%20Kataoka%20H,%20et%20al.%20Glypican%203-Targeted%20therapy%20in%20hepatocellular%20carcinoma.%20Cancers%20(Basel).%202019;11(9):1339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Yamaguchi H, Hsu JM, Yang WH, et al. Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat Rev Clin Oncol. 2022;19:287–305.
</cite> [<a href="https://doi.org/10.1038/s41571-022-00601-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35132224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yamaguchi%20H,%20Hsu%20JM,%20Yang%20WH,%20et%20al.%20Mechanisms%20regulating%20PD-L1%20expression%20in%20cancers%20and%20associated%20opportunities%20for%20novel%20small-molecule%20therapeutics.%20Nat%20Rev%20Clin%20Oncol.%202022;19:287%E2%80%93305." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Barrett AM, Britton ZT, Carrasco RA, et al. Preclinical evaluation of AZD6422, an armored chimeric antigen receptor T cell targeting CLDN18.2 in gastric, pancreatic, and esophageal cancers. Clin Cancer Res. 2024;30(23):5413–29.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-24-1853" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11609629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39321207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barrett%20AM,%20Britton%20ZT,%20Carrasco%20RA,%20et%20al.%20Preclinical%20evaluation%20of%20AZD6422,%20an%20armored%20chimeric%20antigen%20receptor%20T%20cell%20targeting%20CLDN18.2%20in%20gastric,%20pancreatic,%20and%20esophageal%20cancers.%20Clin%20Cancer%20Res.%202024;30(23):5413%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Schaft N, et al. The landscape of CAR-T cell clinical trials against solid Tumors-A comprehensive overview. Cancers (Basel). 2020;12(9):2567.
</cite> [<a href="https://doi.org/10.3390/cancers12092567" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7563774/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32916883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schaft%20N,%20et%20al.%20The%20landscape%20of%20CAR-T%20cell%20clinical%20trials%20against%20solid%20Tumors-A%20comprehensive%20overview.%20Cancers%20(Basel).%202020;12(9):2567." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Qi C, Liu C, Gong J, et al. Claudin18.2-specific CAR T cells in Gastrointestinal cancers: phase 1 trial final results. Nat Med. 2024;30(8):2224–34.
</cite> [<a href="https://doi.org/10.1038/s41591-024-03037-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38830992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qi%20C,%20Liu%20C,%20Gong%20J,%20et%20al.%20Claudin18.2-specific%20CAR%20T%20cells%20in%20Gastrointestinal%20cancers:%20phase%201%20trial%20final%20results.%20Nat%20Med.%202024;30(8):2224%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Cheng CS, Chen J, Tan HY, et al. Scutellaria baicalensis and cancer treatment: recent progress and perspectives in biomedical and clinical studies. Am J Chin Med. 2018;46(1):25–54.
</cite> [<a href="https://doi.org/10.1142/S0192415X18500027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29316796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20CS,%20Chen%20J,%20Tan%20HY,%20et%20al.%20Scutellaria%20baicalensis%20and%20cancer%20treatment:%20recent%20progress%20and%20perspectives%20in%20biomedical%20and%20clinical%20studies.%20Am%20J%20Chin%20Med.%202018;46(1):25%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Kaushik I, Ramachandran S, Zabel C, et al. The evolutionary legacy of immune checkpoint inhibitors. Semin Cancer Biol. 2022;86(Pt 2):491–8.
</cite> [<a href="https://doi.org/10.1016/j.semcancer.2022.03.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35341912/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kaushik%20I,%20Ramachandran%20S,%20Zabel%20C,%20et%20al.%20The%20evolutionary%20legacy%20of%20immune%20checkpoint%20inhibitors.%20Semin%20Cancer%20Biol.%202022;86(Pt%202):491%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Hu Y, Zhou Y, Zhang M, et al. CRISPR/Cas9-Engineered universal CD19/CD22 Dual-Targeted CAR-T cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia. Clin Cancer Res. 2021;27(10):2764–72.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-20-3863" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33627493/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20Y,%20Zhou%20Y,%20Zhang%20M,%20et%20al.%20CRISPR/Cas9-Engineered%20universal%20CD19/CD22%20Dual-Targeted%20CAR-T%20cell%20therapy%20for%20relapsed/refractory%20B-cell%20acute%20lymphoblastic%20leukemia.%20Clin%20Cancer%20Res.%202021;27(10):2764%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Adachi K, Kano Y, Nagai T, et al. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat Biotechnol. 2018;36(4):346–51.
</cite> [<a href="https://doi.org/10.1038/nbt.4086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29505028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Adachi%20K,%20Kano%20Y,%20Nagai%20T,%20et%20al.%20IL-7%20and%20CCL19%20expression%20in%20CAR-T%20cells%20improves%20immune%20cell%20infiltration%20and%20CAR-T%20cell%20survival%20in%20the%20tumor.%20Nat%20Biotechnol.%202018;36(4):346%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Hu W, Zi Z, Jin Y, et al. CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions. Cancer Immunol Immunother. 2019;68(3):365–77.
</cite> [<a href="https://doi.org/10.1007/s00262-018-2281-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11028344/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30523370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20W,%20Zi%20Z,%20Jin%20Y,%20et%20al.%20CRISPR/Cas9-mediated%20PD-1%20disruption%20enhances%20human%20mesothelin-targeted%20CAR%20T%20cell%20effector%20functions.%20Cancer%20Immunol%20Immunother.%202019;68(3):365%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Zheng L, Qin S, Si W, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374(6574):abe6474.
</cite> [<a href="https://doi.org/10.1126/science.abe6474" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34914499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20L,%20Qin%20S,%20Si%20W,%20et%20al.%20Pan-cancer%20single-cell%20landscape%20of%20tumor-infiltrating%20T%20cells.%20Science.%202021;374(6574):abe6474." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Tan R, Li R, Dai MY, et al. Redefining chimeric antigen receptor T-cell (CAR-T) regulation: china’s responses to address secondary cancer risks of CAR-T therapy. J Hematol Oncol. 2024;17(1):90.
</cite> [<a href="https://doi.org/10.1186/s13045-024-01602-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11462758/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39380046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tan%20R,%20Li%20R,%20Dai%20MY,%20et%20al.%20Redefining%20chimeric%20antigen%20receptor%20T-cell%20(CAR-T)%20regulation:%20china%E2%80%99s%20responses%20to%20address%20secondary%20cancer%20risks%20of%20CAR-T%20therapy.%20J%20Hematol%20Oncol.%202024;17(1):90." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Zhang Q, Zu C, Hu Y, et al. CAR-T cells for cancer immunotherapy-the barriers ahead and the paths through. Int Rev Immunol. 2022;41(6):567–81.
</cite> [<a href="https://doi.org/10.1080/08830185.2022.2080820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35635212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Q,%20Zu%20C,%20Hu%20Y,%20et%20al.%20CAR-T%20cells%20for%20cancer%20immunotherapy-the%20barriers%20ahead%20and%20the%20paths%20through.%20Int%20Rev%20Immunol.%202022;41(6):567%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Castaneda Puglianini O, Chavez JC, et al. CARs moving forward: the development of CAR T-Cell therapy in the earlier treatment course of hematologic malignancies. Semin Hematol. 2024;61(5):290–6.
</cite> [<a href="https://doi.org/10.1053/j.seminhematol.2024.08.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39306480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Castaneda%20Puglianini%20O,%20Chavez%20JC,%20et%20al.%20CARs%20moving%20forward:%20the%20development%20of%20CAR%20T-Cell%20therapy%20in%20the%20earlier%20treatment%20course%20of%20hematologic%20malignancies.%20Semin%20Hematol.%202024;61(5):290%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Hernández-López A, Olaya-Vargas A, Bustamante-Ogando JC, et al. Expanding the horizons of CAR-T cell therapy: A review of therapeutic targets across diverse diseases. Pharmaceuticals (Basel). 2025;18(2):156.
</cite> [<a href="https://doi.org/10.3390/ph18020156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11858291/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40005970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hern%C3%A1ndez-L%C3%B3pez%20A,%20Olaya-Vargas%20A,%20Bustamante-Ogando%20JC,%20et%20al.%20Expanding%20the%20horizons%20of%20CAR-T%20cell%20therapy:%20A%20review%20of%20therapeutic%20targets%20across%20diverse%20diseases.%20Pharmaceuticals%20(Basel).%202025;18(2):156." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Zhang P, Zhang G, Wan X, et al. Challenges and new technologies in adoptive cell therapy. J Hematol Oncol. 2023;16(1):97.
</cite> [<a href="https://doi.org/10.1186/s13045-023-01492-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10439661/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37596653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20P,%20Zhang%20G,%20Wan%20X,%20et%20al.%20Challenges%20and%20new%20technologies%20in%20adoptive%20cell%20therapy.%20J%20Hematol%20Oncol.%202023;16(1):97." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Li C, Zhou K, Hu Y, et al. Equecabtagene autoleucel in patients with relapsed or refractory multiple myeloma: the FUMANBA-1 nonrandomized clinical trial. JAMA Oncol. 2024;10(12):1681–8.
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2024.4879" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11544552/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39509090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20C,%20Zhou%20K,%20Hu%20Y,%20et%20al.%20Equecabtagene%20autoleucel%20in%20patients%20with%20relapsed%20or%20refractory%20multiple%20myeloma:%20the%20FUMANBA-1%20nonrandomized%20clinical%20trial.%20JAMA%20Oncol.%202024;10(12):1681%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Wei J, Guo Y, Wang Y, et al. Clinical development of CAR T cell therapy in china: 2020 update. Cell Mol Immunol. 2021;18:792–804.
</cite> [<a href="https://doi.org/10.1038/s41423-020-00555-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8115146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32999455/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20J,%20Guo%20Y,%20Wang%20Y,%20et%20al.%20Clinical%20development%20of%20CAR%20T%20cell%20therapy%20in%20china:%202020%20update.%20Cell%20Mol%20Immunol.%202021;18:792%E2%80%93804." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Sun W, Liang AB, Huang H, et al. Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Chinese experience. Haematologica. 2023;108(8):2011–28.
</cite> [<a href="https://doi.org/10.3324/haematol.2022.282316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10390786/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36794504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20W,%20Liang%20AB,%20Huang%20H,%20et%20al.%20Strategies%20to%20optimize%20chimeric%20antigen%20receptor%20T-cell%20therapy%20in%20hematologic%20malignancies:%20Chinese%20experience.%20Haematologica.%202023;108(8):2011%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Chen W, Fu C, Cai Z, et al. Sustainable efficacy and safety results from lummicar study 1: A phase 1/2 study of fully human B-Cell maturation Antigen-Specific CAR T cells (CT053) in Chinese subjects with relapsed and/or refractory multiple myeloma. Blood. 2021;138(Supplement 1):2821.</cite> [<a href="https://scholar.google.com/scholar_lookup?Chen%20W,%20Fu%20C,%20Cai%20Z,%20et%20al.%20Sustainable%20efficacy%20and%20safety%20results%20from%20lummicar%20study%201:%20A%20phase%201/2%20study%20of%20fully%20human%20B-Cell%20maturation%20Antigen-Specific%20CAR%20T%20cells%20(CT053)%20in%20Chinese%20subjects%20with%20relapsed%20and/or%20refractory%20multiple%20myeloma.%20Blood.%202021;138(Supplement%201):2821." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Wang CZ, Li XL, Wang QF, et al. Selective fraction of scutellaria baicalensis and its chemopreventive effects on MCF-7 human breast cancer cells. Phytomedicine. 2010;17(1):63–8.
</cite> [<a href="https://doi.org/10.1016/j.phymed.2009.07.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2789205/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19836937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20CZ,%20Li%20XL,%20Wang%20QF,%20et%20al.%20Selective%20fraction%20of%20scutellaria%20baicalensis%20and%20its%20chemopreventive%20effects%20on%20MCF-7%20human%20breast%20cancer%20cells.%20Phytomedicine.%202010;17(1):63%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Liao H, Ye J, Gao L, et al. The main bioactive compounds of scutellaria baicalensis Georgi for alleviation of inflammatory cytokines: A comprehensive review. Biomed Pharmacother. 2021;133:110917.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2020.110917" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33217688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liao%20H,%20Ye%20J,%20Gao%20L,%20et%20al.%20The%20main%20bioactive%20compounds%20of%20scutellaria%20baicalensis%20Georgi%20for%20alleviation%20of%20inflammatory%20cytokines:%20A%20comprehensive%20review.%20Biomed%20Pharmacother.%202021;133:110917." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Liu Y, Jia Z, Wang Y, et al. Exploring the mechanisms of Huangqin Qingfei Decoction on acute lung injury by LC-MS combined network Pharmacology analysis. Phytomedicine. 2024;134:155979.
</cite> [<a href="https://doi.org/10.1016/j.phymed.2024.155979" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39208658/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Jia%20Z,%20Wang%20Y,%20et%20al.%20Exploring%20the%20mechanisms%20of%20Huangqin%20Qingfei%20Decoction%20on%20acute%20lung%20injury%20by%20LC-MS%20combined%20network%20Pharmacology%20analysis.%20Phytomedicine.%202024;134:155979." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Jarnicki AG, Lysaght J, Todryk S, et al. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4 + and CD8 + regulatory T cells. J Immunol. 2006;177(2):896–904.
</cite> [<a href="https://doi.org/10.4049/jimmunol.177.2.896" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16818744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jarnicki%20AG,%20Lysaght%20J,%20Todryk%20S,%20et%20al.%20Suppression%20of%20antitumor%20immunity%20by%20IL-10%20and%20TGF-beta-producing%20T%20cells%20infiltrating%20the%20growing%20tumor:%20influence%20of%20tumor%20environment%20on%20the%20induction%20of%20CD4%E2%80%89+%E2%80%89and%20CD8%E2%80%89+%E2%80%89regulatory%20T%20cells.%20J%20Immunol.%202006;177(2):896%E2%80%93904." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Zou Y, Li WY, Wan Z, et al. Huangqin-Tang ameliorates TNBS-Induced colitis by regulating effector and regulatory CD4(+) T cells. Biomed Res Int. 2015;2015:102021.
</cite> [<a href="https://doi.org/10.1155/2015/102021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4539427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26347453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zou%20Y,%20Li%20WY,%20Wan%20Z,%20et%20al.%20Huangqin-Tang%20ameliorates%20TNBS-Induced%20colitis%20by%20regulating%20effector%20and%20regulatory%20CD4(+)%20T%20cells.%20Biomed%20Res%20Int.%202015;2015:102021." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Su G, Chen H, Sun X, et al. Baicalein suppresses Non small cell lung cancer cell proliferation, invasion and Notch signaling pathway. Cancer Biomark. 2018;22(1):13–8.
</cite> [<a href="https://doi.org/10.3233/CBM-170673" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29614624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su%20G,%20Chen%20H,%20Sun%20X,%20et%20al.%20Baicalein%20suppresses%20Non%20small%20cell%20lung%20cancer%20cell%20proliferation,%20invasion%20and%20Notch%20signaling%20pathway.%20Cancer%20Biomark.%202018;22(1):13%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>You J, Cheng J, Yu B, et al. Baicalin, a Chinese herbal medicine, inhibits the proliferation and migration of human Non-Small cell lung carcinoma (NSCLC) cells, A549 and H1299, by activating the SIRT1/AMPK signaling pathway. Med Sci Monit. 2018;24:2126–33.
</cite> [<a href="https://doi.org/10.12659/MSM.909627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5909419/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29632297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?You%20J,%20Cheng%20J,%20Yu%20B,%20et%20al.%20Baicalin,%20a%20Chinese%20herbal%20medicine,%20inhibits%20the%20proliferation%20and%20migration%20of%20human%20Non-Small%20cell%20lung%20carcinoma%20(NSCLC)%20cells,%20A549%20and%20H1299,%20by%20activating%20the%20SIRT1/AMPK%20signaling%20pathway.%20Med%20Sci%20Monit.%202018;24:2126%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Diao X, Yang D, Chen Y, et al. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase. Biosci Rep. 2019;39(4):BSR20181692.
</cite> [<a href="https://doi.org/10.1042/BSR20181692" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6454021/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30898980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Diao%20X,%20Yang%20D,%20Chen%20Y,%20et%20al.%20Baicalin%20suppresses%20lung%20cancer%20growth%20by%20targeting%20PDZ-binding%20kinase/T-LAK%20cell-originated%20protein%20kinase.%20Biosci%20Rep.%202019;39(4):BSR20181692." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Xiong T, Wang G, Yu P et al. CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors. J Clin Invest 2025 Jun 5:e189920.</cite> [<a href="https://doi.org/10.1172/JCI189920" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12321399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40478751/" class="usa-link">PubMed</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Lee BK, Wan Y, Chin ZL, et al. Developing ROR1 targeting CAR-T cells against solid tumors in preclinical studies. Cancers (Basel). 2022;14(15):3618.
</cite> [<a href="https://doi.org/10.3390/cancers14153618" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9331269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35892876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20BK,%20Wan%20Y,%20Chin%20ZL,%20et%20al.%20Developing%20ROR1%20targeting%20CAR-T%20cells%20against%20solid%20tumors%20in%20preclinical%20studies.%20Cancers%20(Basel).%202022;14(15):3618." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Chen L, Chen F, Li J, et al. CAR-T cell therapy for lung cancer: potential and perspective. Thorac Cancer. 2022;13(7):889–99.
</cite> [<a href="https://doi.org/10.1111/1759-7714.14375" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8977151/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35289077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20L,%20Chen%20F,%20Li%20J,%20et%20al.%20CAR-T%20cell%20therapy%20for%20lung%20cancer:%20potential%20and%20perspective.%20Thorac%20Cancer.%202022;13(7):889%E2%80%9399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Si X, Xiao L, Brown CE, et al. Preclinical evaluation of CAR T cell function: in vitro and in vivo models. Int J Mol Sci. 2022;23(6):3154.
</cite> [<a href="https://doi.org/10.3390/ijms23063154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8955360/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35328572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Si%20X,%20Xiao%20L,%20Brown%20CE,%20et%20al.%20Preclinical%20evaluation%20of%20CAR%20T%20cell%20function:%20in%20vitro%20and%20in%20vivo%20models.%20Int%20J%20Mol%20Sci.%202022;23(6):3154." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Liu G, Rui W, Zhao X, et al. Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment. Cell Mol Immunol. 2021;18:1085–95.
</cite> [<a href="https://doi.org/10.1038/s41423-021-00655-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8093220/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33785843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20G,%20Rui%20W,%20Zhao%20X,%20et%20al.%20Enhancing%20CAR-T%20cell%20efficacy%20in%20solid%20tumors%20by%20targeting%20the%20tumor%20microenvironment.%20Cell%20Mol%20Immunol.%202021;18:1085%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Hong JY, An JY, Lee J, et al. Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer. Transl Cancer Res. 2020;9(5):3367–74.
</cite> [<a href="https://doi.org/10.21037/tcr-19-1876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8797704/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35117702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hong%20JY,%20An%20JY,%20Lee%20J,%20et%20al.%20Claudin%2018.2%20expression%20in%20various%20tumor%20types%20and%20its%20role%20as%20a%20potential%20target%20in%20advanced%20gastric%20cancer.%20Transl%20Cancer%20Res.%202020;9(5):3367%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Couzinet A, Suzuki T, Nakatsura T, et al. Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy. Expert Opin Ther Targets. 2024;28(10):895–909.
</cite> [<a href="https://doi.org/10.1080/14728222.2024.2416975" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39428649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Couzinet%20A,%20Suzuki%20T,%20Nakatsura%20T,%20et%20al.%20Progress%20and%20challenges%20in%20glypican-3%20targeting%20for%20hepatocellular%20carcinoma%20therapy.%20Expert%20Opin%20Ther%20Targets.%202024;28(10):895%E2%80%93909." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Komai T, Inoue M, Okamura T, et al. Transforming growth Factor-β and Interleukin-10 synergistically regulate humoral immunity via modulating metabolic signals. Front Immunol. 2018;9:1364.
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.01364" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6010538/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29963056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Komai%20T,%20Inoue%20M,%20Okamura%20T,%20et%20al.%20Transforming%20growth%20Factor-%CE%B2%20and%20Interleukin-10%20synergistically%20regulate%20humoral%20immunity%20via%20modulating%20metabolic%20signals.%20Front%20Immunol.%202018;9:1364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Li W, Zhang X, Wu F, et al. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer. Cell Death Dis. 2019;10(12):918.
</cite> [<a href="https://doi.org/10.1038/s41419-019-2131-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6892854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31801938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20W,%20Zhang%20X,%20Wu%20F,%20et%20al.%20Gastric%20cancer-derived%20mesenchymal%20stromal%20cells%20trigger%20M2%20macrophage%20polarization%20that%20promotes%20metastasis%20and%20EMT%20in%20gastric%20cancer.%20Cell%20Death%20Dis.%202019;10(12):918." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Kyuno D, Takasawa A, Takasawa K, et al. Claudin-18.2 as a therapeutic target in cancers: cumulative findings from basic research and clinical trials. Tissue Barriers. 2022;10(1):1967080.
</cite> [<a href="https://doi.org/10.1080/21688370.2021.1967080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8794250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34486479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kyuno%20D,%20Takasawa%20A,%20Takasawa%20K,%20et%20al.%20Claudin-18.2%20as%20a%20therapeutic%20target%20in%20cancers:%20cumulative%20findings%20from%20basic%20research%20and%20clinical%20trials.%20Tissue%20Barriers.%202022;10(1):1967080." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Qi C, Gong J, Li J, et al. Claudin18.2-specific CAR T cells in Gastrointestinal cancers: phase 1 trial interim results. Nat Med. 2022;28(6):1189–98.
</cite> [<a href="https://doi.org/10.1038/s41591-022-01800-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9205778/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35534566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qi%20C,%20Gong%20J,%20Li%20J,%20et%20al.%20Claudin18.2-specific%20CAR%20T%20cells%20in%20Gastrointestinal%20cancers:%20phase%201%20trial%20interim%20results.%20Nat%20Med.%202022;28(6):1189%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Hu Y, Feng J, Gu T, et al. CAR T-cell therapies in china: rapid evolution and a bright future. Lancet Haematol. 2022;9(12):e930–41.
</cite> [<a href="https://doi.org/10.1016/S2352-3026(22)00291-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36455608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20Y,%20Feng%20J,%20Gu%20T,%20et%20al.%20CAR%20T-cell%20therapies%20in%20china:%20rapid%20evolution%20and%20a%20bright%20future.%20Lancet%20Haematol.%202022;9(12):e930%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Wang CZ, Calway TD, Wen XD, et al. Hydrophobic flavonoids from scutellaria baicalensis induce colorectal cancer cell apoptosis through a mitochondrial-mediated pathway. Int J Oncol. 2013;42(3):1018–26.
</cite> [<a href="https://doi.org/10.3892/ijo.2013.1777" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3576930/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23337959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20CZ,%20Calway%20TD,%20Wen%20XD,%20et%20al.%20Hydrophobic%20flavonoids%20from%20scutellaria%20baicalensis%20induce%20colorectal%20cancer%20cell%20apoptosis%20through%20a%20mitochondrial-mediated%20pathway.%20Int%20J%20Oncol.%202013;42(3):1018%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Erbe H-H, Gingras D, Schuett OE et al. Cost Reducing Engineering Strategies in the Automotive Industry. IFAC Proceedings Volumes. 2004;37(5):305–310.</cite>
</li>
<li id="CR46">
<span class="label">46.</span><cite>Luo C, Wei J, Han W, et al. Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China. Sci China Life Sci. 2016;59(4):349–59.
</cite> [<a href="https://doi.org/10.1007/s11427-016-5034-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27009301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luo%20C,%20Wei%20J,%20Han%20W,%20et%20al.%20Spotlight%20on%20chimeric%20antigen%20receptor%20engineered%20T%20cell%20research%20and%20clinical%20trials%20in%20China.%20Sci%20China%20Life%20Sci.%202016;59(4):349%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Yang J et al. Qingdao’s first case! A compensation of 500,000 yuan [Internet]. Toutiao. 2024 Jun 19 [cited 2025 Jun 25]. Available from: <a href="https://www.toutiao.com/article/7147497472150012448/?upstream_biz=doubao&amp;source=m_redirect" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.toutiao.com/article/7147497472150012448/?upstream_biz=doubao&amp;source=m_redirect</a></cite>
</li>
<li id="CR48">
<span class="label">48.</span><cite>[No author listed]. Hu Huibao has provided supplementary medical security for over 20 million people, with compensation exceeding 1.5 billion yuan [Internet]. Toutiao. 2024 Jun 20 [cited 2025 Jun 25]. Available from: <a href="https://www.toutiao.com/article/7341232739796582924/?upstream_biz=doubao&amp;source=m_redirect" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.toutiao.com/article/7341232739796582924/?upstream_biz=doubao&amp;source=m_redirect</a></cite>
</li>
<li id="CR49">
<span class="label">49.</span><cite>Hu XL et al. Further opening-up key to attracting, keeping intl investment. Chin Daily. 2024 Jan 22. Available from: <a href="https://www.chinadaily.com.cn/a/202401/22/WS65add6b8a3105f21a507d935.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.chinadaily.com.cn/a/202401/22/WS65add6b8a3105f21a507d935.html</a></cite>
</li>
<li id="CR50">
<span class="label">50.</span><cite>Mellatyar H, Sattari S, Asl AN, et al. Recent advances and challenges in cancer treatment with CAR T cell therapy: A novel Anti-cancer strategy. BioNanoSci. 2024;14:4250–62.</cite> [<a href="https://scholar.google.com/scholar_lookup?Mellatyar%20H,%20Sattari%20S,%20Asl%20AN,%20et%20al.%20Recent%20advances%20and%20challenges%20in%20cancer%20treatment%20with%20CAR%20T%20cell%20therapy:%20A%20novel%20Anti-cancer%20strategy.%20BioNanoSci.%202024;14:4250%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Zhang Y, Li T, Wang G, et al. Advancements in Single-Cell RNA sequencing and Spatial transcriptomics for central nervous system disease. Cell Mol Neurobiol. 2024;44(1):65.
</cite> [<a href="https://doi.org/10.1007/s10571-024-01499-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11467076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39387975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Y,%20Li%20T,%20Wang%20G,%20et%20al.%20Advancements%20in%20Single-Cell%20RNA%20sequencing%20and%20Spatial%20transcriptomics%20for%20central%20nervous%20system%20disease.%20Cell%20Mol%20Neurobiol.%202024;44(1):65." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Yeku OO, Purdon TJ, Koneru M, et al. Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment. Sci Rep. 2017;7:10541.
</cite> [<a href="https://doi.org/10.1038/s41598-017-10940-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5585170/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28874817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yeku%20OO,%20Purdon%20TJ,%20Koneru%20M,%20et%20al.%20Armored%20CAR%20T%20cells%20enhance%20antitumor%20efficacy%20and%20overcome%20the%20tumor%20microenvironment.%20Sci%20Rep.%202017;7:10541." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Lim SM, Pyo KH, Soo RA, et al. The promise of bispecific antibodies: clinical applications and challenges. Cancer Treat Rev. 2021;99:102240.
</cite> [<a href="https://doi.org/10.1016/j.ctrv.2021.102240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34119803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lim%20SM,%20Pyo%20KH,%20Soo%20RA,%20et%20al.%20The%20promise%20of%20bispecific%20antibodies:%20clinical%20applications%20and%20challenges.%20Cancer%20Treat%20Rev.%202021;99:102240." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Li YH, Li YL, Wei MY, et al. Innovation and challenges of artificial intelligence technology in personalized healthcare. Sci Rep. 2024;14:18994.
</cite> [<a href="https://doi.org/10.1038/s41598-024-70073-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11329630/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39152194/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20YH,%20Li%20YL,%20Wei%20MY,%20et%20al.%20Innovation%20and%20challenges%20of%20artificial%20intelligence%20technology%20in%20personalized%20healthcare.%20Sci%20Rep.%202024;14:18994." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Kong X, Zhang J, Chen S, et al. Immune checkpoint inhibitors: breakthroughs in cancer treatment. Cancer Biol Med. 2024;21(6):451–72.
</cite> [<a href="https://doi.org/10.20892/j.issn.2095-3941.2024.0055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11208906/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38801082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kong%20X,%20Zhang%20J,%20Chen%20S,%20et%20al.%20Immune%20checkpoint%20inhibitors:%20breakthroughs%20in%20cancer%20treatment.%20Cancer%20Biol%20Med.%202024;21(6):451%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Khoja L, Day D, Chen TW, et al. Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review. Ann Oncol. 2017;28(10):2377–85.
</cite> [<a href="https://doi.org/10.1093/annonc/mdx286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28945858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Khoja%20L,%20Day%20D,%20Chen%20TW,%20et%20al.%20Tumour-%20and%20class-specific%20patterns%20of%20immune-related%20adverse%20events%20of%20immune%20checkpoint%20inhibitors:%20a%20systematic%20review.%20Ann%20Oncol.%202017;28(10):2377%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Brudno JN, Maus MV, Hinrichs CS, et al. CAR T cells and T-Cell therapies for cancer: A translational science review. JAMA. 2024;332(22):1924–35.
</cite> [<a href="https://doi.org/10.1001/jama.2024.19462" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11808657/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39495525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brudno%20JN,%20Maus%20MV,%20Hinrichs%20CS,%20et%20al.%20CAR%20T%20cells%20and%20T-Cell%20therapies%20for%20cancer:%20A%20translational%20science%20review.%20JAMA.%202024;332(22):1924%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Zhang P, Zhang Y, Ji N, et al. Challenges in the treatment of glioblastoma by chimeric antigen receptor T-Cell immunotherapy and possible solutions. Front Immunol. 2022;13:927132.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.927132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9300859/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35874698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20P,%20Zhang%20Y,%20Ji%20N,%20et%20al.%20Challenges%20in%20the%20treatment%20of%20glioblastoma%20by%20chimeric%20antigen%20receptor%20T-Cell%20immunotherapy%20and%20possible%20solutions.%20Front%20Immunol.%202022;13:927132." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Harris PJ, Shaw IC, et al. The contrasting medicines regulatory environments of China and the Western world. Pharm Med. 2015;29:319–22.</cite> [<a href="https://scholar.google.com/scholar_lookup?Harris%20PJ,%20Shaw%20IC,%20et%20al.%20The%20contrasting%20medicines%20regulatory%20environments%20of%20China%20and%20the%20Western%20world.%20Pharm%20Med.%202015;29:319%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Su L, Liu S, Li G, et al. Trends and characteristics of new drug approvals in china, 2011–2021. Ther Innov Regul Sci. 2023;57(2):343–51.
</cite> [<a href="https://doi.org/10.1007/s43441-022-00472-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9628473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36322325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su%20L,%20Liu%20S,%20Li%20G,%20et%20al.%20Trends%20and%20characteristics%20of%20new%20drug%20approvals%20in%20china,%202011%E2%80%932021.%20Ther%20Innov%20Regul%20Sci.%202023;57(2):343%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Discover Oncology are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s12672-025-03282-9"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12672_2025_Article_3282.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12373616/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12373616/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373616%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373616/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12373616/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12373616/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40844635/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12373616/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40844635/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12373616/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12373616/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="o3iC9OF19RolQ0XMEIpdKUDZyBJCITQihZoJ0pf7q6sEToQpuxuKnUuoZ1Giwtxr">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
